The global monoclonal antibody diagnostic reagent market was valued US$ 7,654.06 million in 2021; it is estimated to grow at a CAGR of 13.5% from 2022 to 2028.
Monoclonal antibodies (mAb) are important diagnostic reagents that are being used in biomedical research; microbiological research; in the diagnosis of Hepatitis, AIDs, influenza, herpes simplex, chlamydia infections; and in the treatment of infections and cancer. The monoclonal antibodies being directed at single epitopes are highly specific, homogeneous, and can be produced in unlimited quantities. The hybridoma-derived or bacterially cloned monoclonal antibody technology has enabled the mass production of highly specific probes for antigenic sites, whether on hormones, enzymes, receptors, or microbial products. Major factors driving the growth of this market include the rising prevalence of cancer and other chronic diseases, presence of strong pipeline of drugs under trial, and extensive R&D efforts to develop novel therapies.
The report offers insights and in-depth analysis of the global monoclonal antibody diagnostic reagent market, emphasizing various parameters, including market trends, technological advancements, market dynamics, and competitive landscape analysis of global leading market players. It also includes the impact of the COVID-19 pandemic on the market across all regions.
The overall impact of the COVID-19 pandemic on the monoclonal antibody diagnostic reagent market was positive; hence, the market continues to gain traction and is expected to grow in the coming years. Celltrion Group has announced that the Korean Ministry of Food and Drug Safety (MFDS) has approved regdanvimab (CT-P59), a monoclonal antibody for the treatment of COVID-19 for the prolonged use in elderly patients aged 50 years and over, or with at least one underlying medical condition such as obesity, cardiovascular disease, chronic lung disease, diabetes, chronic kidney disease, chronic liver disease, and patients with immunosuppressive agents with mild symptoms of COVID-19, and adult patients with moderate symptoms of COVID-19. Further, monoclonal antibody therapy, which has been successfully used in other countries to treat COVID-19 patients with mild or moderate symptoms, has now been approved by the Drugs Controller General of India (DCGI) for use in India.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Monoclonal Antibody Diagnostic Reagent Market: Strategic Insights
Market Size Value in US$ 7,654.06 Million in 2021 Market Size Value by US$ 18,507.20 Million by 2028 Growth rate CAGR of 13.5% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Monoclonal Antibody Diagnostic Reagent Market: Strategic Insights
| Market Size Value in | US$ 7,654.06 Million in 2021 |
| Market Size Value by | US$ 18,507.20 Million by 2028 |
| Growth rate | CAGR of 13.5% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Geography-Based Insights
By geography, the global monoclonal antibody diagnostic reagent market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Russia, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, Kazakhstan, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Lucrative Regions for Monoclonal Antibody Diagnostic Reagent Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Extensive R&D Efforts to Develop Novel Therapies
The numerous application of mAbs involves the prevention, diagnosis, and treatment of disease. The application of mAbs in diagnosis is the most advanced, particularly for tests performed on the body fluids such as urine and blood. Additionally, mAbs diagnostic application includes techniques such as ELISA, western blot, immunoblot blot, flow cytometry, immunohistochemistry, radioimmunology assay, and electron microscopy. Also, mAbs intended for diagnostic application can detect antigens and antibodies against viral and fungal diseases of livestock and parasitic diseases.
Further, mAbs are valued reagents intended for abundant applications due to its selectivity, high binding affinity, and immunogenicity/low toxicity; mAbs are best suited for clinical, environmental, and elemental research. The diagnostic applications of mAbs also include medical devices, vitro tests, and medical imaging
Moreover, the utility of mAbs expanded for understanding a range of diseases by contributing to developing new immunotherapy treatments. For example, cancer therapies benefitted from research with mAbs, most probably for the development of RituximAb, proving an effective treatment for many cancers. Also, many mAbs are now recognized by the US Food and Drug Administration (FDA) as safe for utilization in commercial therapeutics. Such factors mentioned above are expected to contribute to the monoclonal antibody diagnostic reagent market growth during the forecast period.
Tests-Based Insights
Based on tests, the global monoclonal antibody diagnostic reagent market is segmented into double antigen sandwich chemiluminescence method, enzyme linked immunosorbent assay, recombinant immunoblot assay, and dot-immunogold filtration assay. In 2021, the enzyme-linked immunosorbent assay segment accounted for the largest market share, and it is anticipated to register the highest CAGR from 2022 to 2028.
Global Monoclonal Antibody Diagnostic Reagent Market, by Tests – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Application-Based Insights
Based on application, the global monoclonal antibody diagnostic reagent market is segmented into hormones diagnosis, tumor monitoring, virus detection, and other application. The tumor monitoring segment held the largest market share in 2021, and it is expected to register the highest CAGR during the forecast period.
The global monoclonal antibody diagnostic reagent market players are adopting organic strategies, including product launch and expansion, to expand their footprint and product portfolio worldwide and meet the growing product demand. A few of the key players operating in the market are BioGenex; Bio-Rad Laboratories, Inc.; Biocare Medical, LLC; Celltrion Healthcare Co., Ltd.; Creative Diagnostics; GenWay Biotech; Thermo Fisher Scientific Inc.; ABclonal, Inc.; Apto-Gen; and Abcam plc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Tests and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, UAE, UK, US
Frequently Asked Questions
Monoclonal antibodies (mAb) are important diagnostic reagents that are being used in biomedical research, microbiological research in diagnosis of Hepatitis, AIDs, influenza, herpes simplex, chlamydia infections and in treatment of infections and cancer. The monoclonal antibodies being directed against single epitopes are highly specific, homogeneous and can be produced in unlimited quantities. The hybridoma-derived or bacterially cloned monoclonal antibody technology has enabled the mass production of highly specific probes for antigenic sites, whether on hormones, enzymes, receptors, or microbial products.
Rising prevalence of cancer and other chronic diseases, extensive R&D efforts to develop novel therapies, and presence of strong pipeline of drugs under trial are the major factors contributing to the growth of the monoclonal antibody diagnostic reagent industry.
The monoclonal antibody diagnostic reagent market majorly consists of the players, such as BioGenex; Bio-Rad Laboratories, Inc.; Biocare Medical, LLC; Celltrion Healthcare Co., Ltd.; Creative Diagnostics; GenWay Biotech; Thermo Fisher Scientific Inc.; ABclonal, Inc.; Apto-Gen; and Abcam plc.
The CAGR value of the monoclonal antibody diagnostic reagent market during the forecasted period of 2022-2028 is 13.5%
The monoclonal antibody diagnostic reagent market is estimated to be valued at US$ 8,642.00 million in 2022.
The monoclonal antibody diagnostic reagent market is expected to be valued at US$ 18,507.20 million in 2028.
The enzyme-linked immunosorbent assay segment held the largest share of the market in the global monoclonal antibody diagnostic reagent market contributing a market share of 37.89% in 2021.
The Asia Pacific is expected to be the fastest-growing region in the monoclonal antibody diagnostic reagent market over the forecast period due to growing investments from international players in China and India, increasing disposable income, and chronic diseases in these regions will show promising growth in the monoclonal antibody diagnostic reagent market.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Monoclonal Antibody Diagnostic Reagent Market – By Tests
1.3.2 Global Monoclonal Antibody Diagnostic Reagent Market – By Application
1.3.3 Global Monoclonal Antibody Diagnostic Reagent Market – By Geography
2. Monoclonal Antibody Diagnostic Reagent Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Monoclonal Antibody Diagnostic Reagent Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East & Africa – PEST Analysis
4.2.5 South & Central America – PEST Analysis
4.3 Expert Opinion
5. Monoclonal Antibody Diagnostic Reagent Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Cancer and Other Chronic Diseases
5.1.2 Extensive R&D Efforts to Develop Novel Therapies
5.1.3 Presence of Strong Pipeline of Drugs Under Trial
5.2 Market Restraints
5.2.1 Low Awareness, Accessibility, and High Cost
5.3 Market Opportunities
5.3.1 Cost-effective Advanced Technology for Developing mAbs Presents Billion-Dollar Opportunity
5.4 Future Trends
5.4.1 Strategic Research Collaborations
5.5 Impact Analysis
6. Monoclonal Antibody Diagnostic Reagent Market – Global Analysis
6.1 Global Monoclonal Antibody Diagnostic Reagent Market - Revenue Forecast and Analysis
6.1.1 Global Monoclonal Antibody Diagnostic Reagent Market, By Geography - Forecast and Analysis
6.1.2 Global Monoclonal Antibody Diagnostic Reagent Market – Market Potential Analysis, By Region
6.2 Company Analysis
6.2.1 Market Positioning of Key Players
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance of Key Players
6.2.4.1 Thermo Fisher Scientific Inc.
6.2.4.2 Bio-Rad Laboratories, Inc.
7. Global Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast To 2028 – by Tests
7.1 Overview
7.2 Global Monoclonal Antibody Diagnostic Reagent Market, By Tests, 2021 & 2028 (%)
7.3 Double Antigen Sandwich Chemiluminescence Method
7.3.1 Overview
7.3.2 Double Antigen Sandwich Chemiluminescence Method: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Enzyme Linked Immunosorbent Assay (ELISA)
7.4.1 Overview
7.4.2 Enzyme Linked Immunosorbent Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Recombinant Immunoblot Assay (RIBA)
7.5.1 Overview
7.5.2 Recombinant Immunoblot Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Dot-immunogold Filtration Assay
7.6.1 Overview
7.6.2 Dot-immunogold Filtration Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
8. Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 Global Monoclonal Antibody Diagnostic Reagent Market Share by Application Segment - 2021 & 2028 (%)
8.3 Hormones Diagnosis
8.3.1 Overview
8.3.2 Hormones Diagnosis: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
8.4 Tumor Monitoring
8.4.1 Overview
8.4.2 Tumor Monitoring: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
8.5 Virus Detection
8.5.1 Overview
8.5.2 Virus Detection: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
8.6 Other Applications
8.6.1 Overview
8.6.2 Other Applications: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
9. Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 – Geographical Analysis
9.1 North America: Monoclonal Antibody Diagnostic Reagent Market
9.1.1 Overview
9.1.2 North America: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3 North America: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)
9.1.4 North America: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)
9.1.5 North America: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Monoclonal Antibody Diagnostic Reagent Market– Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 Overview
9.1.5.1.2 US: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.3 US: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)
9.1.5.1.4 US: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)
9.1.5.2 Canada: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.1 Overview
9.1.5.2.2 Canada: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.3 Canada: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)
9.1.5.2.4 Canada: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)
9.1.5.3 Mexico: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 Overview
9.1.5.3.2 Mexico: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.3 Mexico: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)
9.1.5.3.4 Mexico: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)
9.2 Europe: Monoclonal Antibody Diagnostic Reagent Market
9.2.1 Overview
9.2.2 Europe: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.2.3 Europe: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
9.2.4 Europe: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
9.2.5 Europe: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2022 & 2028 (%)
9.2.5.1 UK: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.1 Overview
9.2.5.1.2 UK: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.3 UK: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.4 UK: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2 Germany: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.1 Overview
9.2.5.2.2 Germany: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.3 Germany: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.4 Germany: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3 France: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 Overview
9.2.5.3.2 France: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.3 France: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.4 France: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4 Italy: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.1 Overview
9.2.5.4.2 Italy: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.3 Italy: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.4 Italy: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5 Spain: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 Overview
9.2.5.5.2 Spain: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.3 Spain: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.4 Spain: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6 Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Overview
9.2.5.6.2 Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.3 Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.4 Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
9.3 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market
9.3.1 Overview
9.3.2 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecast to 2028 (US$ Million)
9.3.3 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)
9.3.4 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)
9.3.5 Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2021 & 2028 (%)
9.3.5.1 China: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.1 Overview
9.3.5.1.2 China: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.3 China: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)
9.3.5.1.4 China: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)
9.3.5.2 Japan: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.1 Overview
9.3.5.2.2 Japan: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.3 Japan: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)
9.3.5.2.4 Japan: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)
9.3.5.3 India: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.1 Overview
9.3.5.3.2 India: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.3 India: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)
9.3.5.3.4 India: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)
9.3.5.4 South Korea: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.1 South Korea: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.2 South Korea: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)
9.3.5.4.3 South Korea: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)
9.3.5.5 Australia: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.1 Australia: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.2 Australia: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)
9.3.5.5.3 Australia: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)
9.3.5.6 Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.1 Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.2 Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2019–2028 (US$ Million)
9.3.5.6.3 Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Application, 2019–2028 (US$ Million)
9.4 Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast To 2028
9.4.1 Overview
9.4.2 Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
9.4.3 Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
9.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Application (US$ Million)
9.4.5 Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2022 & 2028 (%)
9.4.5.1 Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
9.4.5.1.1 Overview
9.4.5.1.2 Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
9.4.5.1.3 Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
9.4.5.1.4 Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast To 2028, By Application (US$ Million)
9.4.5.2 South Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
9.4.5.2.1 Overview
9.4.5.2.2 South Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
9.4.5.2.3 South Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
9.4.5.2.4 South Africa: Metabolomics Market Revenue and Forecast To 2028, By Application (US$ Million)
9.4.5.3 UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
9.4.5.3.1 Overview
9.4.5.3.2 UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
9.4.5.3.3 UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
9.4.5.3.4 UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast To 2028, By Application (US$ Million)
9.4.5.4 Rest of Middle East and Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
9.4.5.4.1 Overview
9.4.5.4.2 Rest of Middle East and Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
9.4.5.4.3 Rest of Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
9.4.5.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast To 2028, By Application (US$ Million)
9.5 South And Central America: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecasts To 2028
9.5.1 Overview
9.5.2 South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
9.5.3 South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)
9.5.4 South and Central America: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
9.5.5 South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Country (%)
9.5.5.1 Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.1.1 Overview
9.5.5.1.2 Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.1.3 Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)
9.5.5.1.4 Brazil: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
9.5.5.2 Argentina: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecasts to 2028 (US$ Million)
9.5.5.2.1 Overview
9.5.5.2.2 Argentina Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.2.3 Argentina: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)
9.5.5.2.4 Argentina: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
9.5.5.3 Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market– Revenue and Forecast to 2028 (USD Mn)
9.5.5.3.1 Overview
9.5.5.3.2 Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market– Revenue and Forecast to 2028 (USD Mn)
9.5.5.3.3 Rest of South & Central America: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecasts to 2028, By Tests (US$ Million)
9.5.5.3.4 Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10. Impact Of COVID-19 Pandemic on Monoclonal Antibody Diagnostic Reagent Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Monoclonal Antibody Diagnostic Reagent Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Monoclonal Antibody Diagnostic Reagent Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 BioGenex
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Bio-Rad Laboratories, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Biocare Medical, LLC
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Celltrion Healthcare Co.,Ltd.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Creative Diagnostics
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 GenWay Biotech
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Thermo Fisher Scientific Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 ABclonal, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Apto-Gen
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Abcam plc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms for Benign Prostatic Hyperplasia Devices Market
LIST OF TABLES
Table 1. North America Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 9. Europe: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
Table 10. Europe: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 11. UK: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
Table 12. UK: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 13. Germany: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
Table 14. Germany: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 15. France: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
Table 16. France: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 19. Spain: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market, by Tests– Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 23. Asia Pacific Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)
Table 24. Asia Pacific Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 25. China Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)
Table 26. China Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 27. Japan Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)
Table 28. Japan Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 29. India Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)
Table 30. India Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 31. South Korea Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)
Table 32. South Korea Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 33. Australia Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)
Table 34. Australia Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market, by Tests – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 37. Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
Table 38. Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 39. Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
Table 40. Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 41. South Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
Table 42. South Africa: Metabolomics Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 43. UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
Table 44. UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 45. Rest of Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028, By Test (US$ Million)
Table 46. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Application (US$ Million)
Table 47. South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)
Table 48. South and Central America: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 49. Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)
Table 50. Brazil: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 51. Argentina: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Tests (US$ Million)
Table 52. Argentina: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of South & Central America: Monoclonal Antibody Diagnostic Reagent Market - Revenue and Forecasts to 2028, By Tests (US$ Million)
Table 54. Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 55. Organic Developments in the Monoclonal Antibody Diagnostic Reagent Market
Table 56. Inorganic Developments in the Monoclonal Antibody Diagnostic Reagent Market
Table 57. Glossary of Terms
LIST OF FIGURES
Figure 1. Monoclonal Antibody Diagnostic Reagent Market Segmentation
Figure 2. Monoclonal Antibody Diagnostic Reagent Market, By Region
Figure 3. Global Monoclonal Antibody Diagnostic Reagent Market Overview
Figure 4. Enzyme Linked Immunosorbent Segment Held Largest Share of Tests Segment in Monoclonal Antibody Diagnostic Reagent Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Monoclonal Antibody Diagnostic Reagent Market, by Geography (US$ Million)
Figure 7. Global Monoclonal Antibody Diagnostic Reagent Market - Leading Country Markets (US$ Million)
Figure 8. Global Monoclonal Antibody Diagnostic Reagent Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Impact Analysis of Drivers and Restraints Pertaining to Monoclonal Antibody Diagnostic Reagent Market
Figure 15. Global Monoclonal Antibody Diagnostic Reagent Market – Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Monoclonal Antibody Diagnostic Reagent Market – By Geography Forecast and Analysis – 2022- 2028
Figure 17. Global Monoclonal Antibody Diagnostic Reagent Market – Market Potential Analysis, By Region
Figure 18. Market Positioning of Key Players in Global Monoclonal Antibody Diagnostic Reagent Market
Figure 19. Global Monoclonal Antibody Diagnostic Reagent Market – Comparative Company Analysis
Figure 20. Global Monoclonal Antibody Diagnostic Reagent Market – Growth Strategy Analysis
Figure 21. Global Monoclonal Antibody Diagnostic Reagent Market, by Tests, 2021 & 2028 (%)
Figure 22. Double Antigen Sandwich Chemiluminescence Method: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Enzyme Linked Immunosorbent Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Recombinant Immunoblot Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Dot-immunogold Filtration Assay: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Global Monoclonal Antibody Diagnostic Reagent Market Share by Application Segment - 2021 & 2028 (%)
Figure 27. Hormones Diagnosis: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Tumor Monitoring: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. Virus Detection: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Other Applications: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. North America: Monoclonal Antibody Diagnostic Reagent Market, by Key Country – Revenue (2021) (US$ Million)
Figure 32. North America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2021 & 2028 (%)
Figure 34. US: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Canada: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Mexico: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Europe: Monoclonal Antibody Diagnostic Reagent Market, by Key Country – Revenue (2021) (US$ Million)
Figure 38. Europe: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. Europe: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2022 & 2028 (%)
Figure 40. UK: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Germany: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. France: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Italy: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Spain: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Rest of Europe: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Key Country – Revenue (2021) (US$ Million)
Figure 47. Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
Figure 48. Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2021 & 2028 (%)
Figure 49. China: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Japan: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. India: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. South Korea: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Australia: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Rest of Asia Pacific: Monoclonal Antibody Diagnostic Reagent Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 56. Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
Figure 57. Middle East & Africa: Monoclonal Antibody Diagnostic Reagent Market, by Country, 2022 & 2028 (%)
Figure 58. Saudi Arabia: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
Figure 59. South Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
Figure 60. UAE: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
Figure 61. Rest of Middle East and Africa: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecast to 2028 (US$ Million)
Figure 62. South and Central America: Monoclonal Antibody Diagnostic Reagent Market - Revenue Overview, by Country, 2022 (US$ Million)
Figure 63. South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
Figure 64. South and Central America Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028, By Country (%)
Figure 65. Brazil: Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
Figure 66. Argentina Monoclonal Antibody Diagnostic Reagent Market Revenue and Forecasts to 2028 (US$ Million)
Figure 67. Rest of South and Central America: Monoclonal Antibody Diagnostic Reagent Market– Revenue and Forecast to 2028 (USD Mn)
Figure 68. Impact of COVID-19 Pandemic in North American Countries Markets
Figure 69. Impact of COVID-19 Pandemic in European Country Markets
Figure 70. Impact of COVID-19 Pandemic in Asia-Pacific Countries Markets
Figure 71. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 72. Impact of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 73. Growth Strategies in the Monoclonal Antibody Diagnostic Reagent Market (%)
The List of Companies - Monoclonal Antibody Diagnostic Reagent Market
- BioGenex
- Bio-Rad Laboratories, Inc.
- Biocare Medical, LLC
- Celltrion Healthcare Co., Ltd.
- Creative Diagnostics
- GenWay Biotech
- Thermo Fisher Scientific Inc.
- ABclonal, Inc.
- Apto-Gen
- Abcam plc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Monoclonal Antibody Diagnostic Reagent Market
Sep 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Sep 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Sep 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)